A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer |
| |
| Authors: | Yuchen Guo Yangyang Zhou Wenxin Qin |
| |
| Affiliation: | 1.State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200032, China |
| |
| Abstract: | Recently, in cooperation with the Netherlands Cancer Institute, we demonstrated that epidermal growth factor receptor (EGFR) activation limited the response of ... |
| |
| Keywords: | |
|
|
